Cargando…

Correlates of Protection for M Protein-Based Vaccines against Group A Streptococcus

Group A streptococcus (GAS) is known to cause a broad spectrum of illness, from pharyngitis and impetigo, to autoimmune sequelae such as rheumatic heart disease, and invasive diseases. It is a significant cause of infectious disease morbidity and mortality worldwide, but no efficacious vaccine is cu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsoi, Shu Ki, Smeesters, Pierre R., Frost, Hannah R. C., Licciardi, Paul, Steer, Andrew C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458553/ https://www.ncbi.nlm.nih.gov/pubmed/26101780 http://dx.doi.org/10.1155/2015/167089

Ejemplares similares

Validation of an automated colony counting system for group A Streptococcus
por: Frost, H. R., et al.
Publicado: (2016)

Analysis of Global Collection of Group A Streptococcus Genomes Reveals that the Majority Encode a Trio of M and M-Like Proteins
por: Frost, Hannah R., et al.
Publicado: (2020)

An emm-type specific qPCR to track bacterial load during experimental human Streptococcus pyogenes pharyngitis
por: Fabri, Loraine V., et al.
Publicado: (2021)

Added Value of the emm-Cluster Typing System to Analyze Group A Streptococcus Epidemiology in High-Income Settings
por: Shulman, Stanford T., et al.
Publicado: (2014)

Promiscuous evolution of Group A Streptococcal M and M-like proteins
por: Frost, Hannah R., et al.
Publicado: (2023)

Immune Cross-Opsonization Withinemm Clusters Following Group AStreptococcus Skin Infection: Broadening the Scope of Type-Specific Immunity
por: Frost, Hannah R, et al.
Publicado: (2017)

Molecular Epidemiology of Group A Streptococcus Infections in Cambodian Children, 2007–2012
por: Turner, Paul, et al.
Publicado: (2015)

Comparative M-protein analysis of Streptococcus pyogenes from pharyngitis and skin infections in New Zealand: Implications for vaccine development
por: Williamson, Deborah A, et al.
Publicado: (2016)

The Path to Group A Streptococcus Vaccines: World Health Organization Research and Development Technology Roadmap and Preferred Product Characteristics
por: Vekemans, Johan, et al.
Publicado: (2019)

Correlates of immunity to Group A Streptococcus: a pathway to vaccine development
por: Frost, Hannah, et al.
Publicado: (2023)

A Controlled Human Infection Model of Group A Streptococcus Pharyngitis: Which Strain and Why?
por: Osowicki, Joshua, et al.
Publicado: (2019)

Immune signature of acute pharyngitis in a Streptococcus pyogenes human challenge trial
por: Anderson, Jeremy, et al.
Publicado: (2022)

Increase in bloodstream infections caused by emm1 group A Streptococcus correlates with emergence of toxigenic M1(UK), Belgium, May 2022 to August 2023
por: Rodriguez-Ruiz, Juan Pablo, et al.
Publicado: (2023)

Science that "knows" and science that "asks"
por: Smeesters, Pierre R, et al.
Publicado: (2011)

Polymeric epitope-based vaccine induces protective immunity against group A Streptococcus
por: Chen, Shuxiong, et al.
Publicado: (2023)

Differences between Belgian and Brazilian Group A Streptococcus Epidemiologic Landscape
por: Smeesters, Pierre Robert, et al.
Publicado: (2006)

Group A streptococcal strains isolated in Lao People's Democratic Republic from 2004 to 2013
por: RATTANAVONG, S., et al.
Publicado: (2016)

Molecular Epidemiology of Group A Streptococcus Infections in The Gambia
por: Jabang, Sona, et al.
Publicado: (2021)

The Streptococcus pyogenes vaccine landscape
por: Walkinshaw, Donald R., et al.
Publicado: (2023)

Cost-effectiveness analysis of maternal vaccination against Group B streptococcus in Japan
por: Sorano, Sumire, et al.
Publicado: (2023)

Invasive Group A Streptococcus Infection among Children, Rural Kenya
por: Seale, Anna C., et al.
Publicado: (2016)

Progress towards a glycoconjugate vaccine against Group A Streptococcus
por: Burns, Keira, et al.
Publicado: (2023)

Detection of group a streptococcal pharyngitis by quantitative PCR
por: Dunne, Eileen M, et al.
Publicado: (2013)

Novel platform technology for modular mucosal vaccine that protects against streptococcus
por: Zaman, Mehfuz, et al.
Publicado: (2016)

A Vaccine Against Group B Streptococcus: Recent Advances
por: Carreras-Abad, Clara, et al.
Publicado: (2020)

Immunization With a Secreted Esterase Protects Mice Against Multiple Serotypes (M1, M3, and M28) of Group A Streptococcus
por: Zhang, Xiaolan, et al.
Publicado: (2020)

Poly(hydrophobic Amino Acids) and Liposomes for Delivery of Vaccine against Group A Streptococcus
por: Azuar, Armira, et al.
Publicado: (2022)

Rational Design of a Glycoconjugate Vaccine against Group A Streptococcus
por: Di Benedetto, Roberta, et al.
Publicado: (2020)

Update on the development of Group A Streptococcus vaccines
por: Ajay Castro, Sowmya, et al.
Publicado: (2023)

Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations
por: Zühlke, Liesl J., et al.
Publicado: (2017)

Maternal vaccination with a type-III glycoconjugate protects mouse neonates against Group B Streptococcus intranasal infection
por: Chiarot, Emiliano, et al.
Publicado: (2021)

GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus
por: Palmieri, Elena, et al.
Publicado: (2022)

Vaccine-Induced Th1-Type Response Protects against Invasive Group A Streptococcus Infection in the Absence of Opsonizing Antibodies
por: Rivera-Hernandez, Tania, et al.
Publicado: (2020)

Mechanism of Protection Induced by Group A Streptococcus Vaccine Candidate J8-DT: Contribution of B and T-Cells Towards Protection
por: Pandey, Manisha, et al.
Publicado: (2009)

Invasive Group A Streptococcal Infections: Benefit of Clindamycin, Intravenous Immunoglobulins and Secondary Prophylaxis
por: Laho, Delphine, et al.
Publicado: (2021)

1454. Β-Hemolytic Non-Group A Streptococcus Pharyngitis in Children
por: Frost, Holly M, et al.
Publicado: (2018)

Recent Advances in the Development of Peptide Vaccines and Their Delivery Systems against Group A Streptococcus
por: Azuar, Armira, et al.
Publicado: (2019)

A Safe and Stable Neonatal Vaccine Targeting GAPDH Confers Protection against Group B Streptococcus Infections in Adult Susceptible Mice
por: Alves, Joana, et al.
Publicado: (2015)

Human monoclonal antibodies to group B streptococcus. Reactivity and in vivo protection against multiple serotypes
Publicado: (1988)

Streptococcus pneumoniae controlled human infection models: Opportunities and challenges
por: Licciardi, Paul V.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fogngohrc58ogoo3a807ss8eqa